Table of Contents

company-logo

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Soleno Therapeutics Dividend Announcement

• Soleno Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Soleno Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Soleno Therapeutics Dividend History

Soleno Therapeutics Dividend Yield

Soleno Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Soleno Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Soleno Therapeutics Financial Ratios

P/E ratio-18.27
PEG ratio-12.93
P/B ratio9.05
ROE-61.99%
Payout ratio0.00%
Current ratio17.26
Quick ratio17.26
Cash Ratio3.24

Soleno Therapeutics Dividend FAQ

Does Soleno Therapeutics stock pay dividends?
Soleno Therapeutics does not currently pay dividends to its shareholders.
Has Soleno Therapeutics ever paid a dividend?
No, Soleno Therapeutics has no a history of paying dividends to its shareholders. Soleno Therapeutics is not known for its dividend payments.
Why doesn't Soleno Therapeutics pay dividends?
There are several potential reasons why Soleno Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Soleno Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Soleno Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Soleno Therapeutics a dividend aristocrat?
Soleno Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Soleno Therapeutics a dividend king?
Soleno Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Soleno Therapeutics a dividend stock?
No, Soleno Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Soleno Therapeutics stocks?
To buy Soleno Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Soleno Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.